OPKO Health (OPK) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.59 -3.05%
Revenue Growth %: -11.2%
Financial Fact:
Selling, general and administrative: 124.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -11.2%
Financial Fact:
Selling, general and administrative: 124.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $185.4 million versus the consensus estimate of $168.21 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Canaan Inc. (CAN) PT Lowered to $2 at BTIG
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
